Discover 427 paid clinical trials in Lexington, Kentucky. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 427
A Multicenter Study to Evaluate Safety, Tolerability, and Clinical Responses of DSP-1083 Into Subjects With Parkinson's Disease
for
Parkinson's Disease
Location: Lexington KY, New York NY, La Jolla CA
Sponsor: Sumitomo Pharma America, Inc.
Sex: All
Age: 40 - 70+
Code: NCT06753331
Phase 1, Phase 2, Recruiting
New
Skills Training and Relief for Orofacial Pain
for
Chronic Orofacial Pain, Orofacial Pain
Location: Lexington KY
Sponsor: University of Kentucky
Sex: All
Age: 18+
Code: NCT07802067
Recruiting
Preventing Injured Knees From osteoArthritis: Severity Outcomes
Impact of Daily Oral Cannabis Doses in Patients With Cancer
for
Cancer, Cancers, Pain
Location: Lexington KY
Sponsor: Shanna Babalonis, PhD
Sex: All
Age: 18+
Code: NCT06601218
Phase 1, Recruiting
Abatacept in Immune Checkpoint Inhibitor Myocarditis
for
Myocarditis Acute, Cancer
Location: Lexington KY, Indianapolis IN, Morgantown WV,
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT05335928
Phase 3, Recruiting
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
Clinical Trial Evaluating the Safety and Efficacy of Nucleus Pulposus Allograft in Participants With Degenerative Disc Disease
for
Degenerative Disc Disease, Disc Degeneration,
Location: Lexington KY, New Castle IN, Charleston WV,
Sponsor: VIVEX Biologics, Inc.
Sex: All
Age: 22 - 70+
Code: NCT06778447
Recruiting
A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)
for
Non-small Cell Lung Cancer
Location: Lexington KY, Baltimore MD, Philadelphia PA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06731907
Phase 2, Recruiting
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)